MAPT, microtubule associated protein tau, 4137

N. diseases: 469; N. variants: 292
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0751295
Disease: Memory Loss
Memory Loss
0.370 Biomarker phenotype BEFREE Brain aging and Alzheimer's disease both demonstrate the accumulation of beta-amyloid protein containing "plaques" and tau protein containing "tangles" that contribute to accelerated memory loss and cognitive decline. 30728442 2019
CUI: C0751295
Disease: Memory Loss
Memory Loss
0.370 Biomarker phenotype BEFREE This study investigated if resveratrol (RES) can protect against cadmium chloride (CdCl<sub>2</sub>)-induced memory loss and Tau protein hyperphosphorylation in rats and explored its effect on AMPK/PI3K/Akt signaling pathway. 30478674 2019
CUI: C0751295
Disease: Memory Loss
Memory Loss
0.370 Biomarker phenotype BEFREE The tau protein aggregates in aging and Alzheimer disease and may lead to memory loss through disruption of medial temporal lobe (MTL)-dependent memory systems. 31653847 2019
CUI: C0751295
Disease: Memory Loss
Memory Loss
0.370 Biomarker phenotype CTD_human Importance of tau in cognitive decline as revealed by developmental exposure to lead. 29203278 2018
CUI: C0751295
Disease: Memory Loss
Memory Loss
0.370 GeneticVariation phenotype BEFREE MAPT p.R406W carriers present clinically with progressive memory loss and neuropathologically with neuronal and glial tauopathy. 30546007 2018
CUI: C0751295
Disease: Memory Loss
Memory Loss
0.370 Biomarker phenotype CTD_human Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy. 29860433 2018
CUI: C0751295
Disease: Memory Loss
Memory Loss
0.370 Biomarker phenotype BEFREE Alzheimer's disease (AD) is a neurodegenerative disorder characterized by loss of memory and cognitive abilities, and the appearance of amyloid plaques composed of the amyloid-β peptide (Aβ) and neurofibrillary tangles formed of tau protein. 25763997 2016
CUI: C0751295
Disease: Memory Loss
Memory Loss
0.370 Biomarker phenotype CTD_human Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity. 24556215 2014
CUI: C0751295
Disease: Memory Loss
Memory Loss
0.370 Biomarker phenotype CTD_human A proteomic analysis of MCLR-induced neurotoxicity: implications for Alzheimer's disease. 22430071 2012
CUI: C0751295
Disease: Memory Loss
Memory Loss
0.370 AlteredExpression phenotype BEFREE It is widely known that exogenous formaldehyde exposure induces human cognitive impairment and animal memory loss; and recent studies show that formaldehyde at pathological levels induces Aβ deposition and misfolding of tau protein to form globular amyloid-like aggregates. 19879019 2011
CUI: C0751295
Disease: Memory Loss
Memory Loss
0.370 AlteredExpression phenotype BEFREE To identify other neurotoxic tau protein species, we performed biochemical analyses on brain tissues from the rTg4510 mouse model and then correlated the levels of these tau proteins with memory loss. 17409229 2007
CUI: C0751295
Disease: Memory Loss
Memory Loss
0.370 Biomarker phenotype CTD_human Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. 12368474 2002